Cost-comparison analysis versus cost-effectiveness analysis: An important difference

被引：5

作者：

Chen, S

Bayoumi, AM

Goldstein, MK

机构：

[1] Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA

[3] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada

[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[5] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1999年 / 41卷 / 06期

关键词：

D O I：

10.1016/S0190-9622(99)70279-3

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1050 / 1050

页数：1

共 3 条

[1] Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis - A pilot study [J].

Chen, S ;

Shaheen, A ;

Garber, A .

ARCHIVES OF DERMATOLOGY, 1998, 134 (12) :1602-1608

[2] Recommendations of the panel on cost-effectiveness in health and medicine [J].

Weinstein, MC ;

Siegel, JE ;

Gold, MR ;

Kamlet, MS ;

Russell, LB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (15) :1253-1258

[3] ASSESSING THE PREFERENCES OF PATIENTS WITH PSORIASIS - A QUANTITATIVE, UTILITY APPROACH [J].

ZUG, KA ;

LITTENBERG, B ;

BAUGHMAN, RD ;

KNEELAND, T ;

NEASE, RF ;

SUMNER, W ;

OCONNOR, GT ;

JONES, R ;

MORRISON, E ;

CIMIS, R .

ARCHIVES OF DERMATOLOGY, 1995, 131 (05) :561-568

← 1 →